SCHEMBL31489074

SCHEMBL31489074

CCOC(=O)[C@@H](CO)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.52
LMNA P02545 3/20 0.52
ALDH1A1 P00352 2/20 0.52
POLB P06746 2/20 0.52
HSD17B10 Q99714 1/20 0.52
MMP8 P22894 1/20 0.46
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
PIN1 Q13526 1/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
NPBWR1 P48145 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MCHR1 Q99705 1/20 0.42
EPOR P19235 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13064940 1.00 L3MBTL1 (0.52) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL3632576 0.89 L3MBTL1 (0.54) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL23027133 0.88 ALDH1A1 (0.52) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL25060413 0.88 ALDH1A1 (0.52) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL3363612 0.86 EPOR (0.54) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL1697393 0.86 EPOR (0.54) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL15448254 0.86 ALDH1A1 (0.47) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL10315706 0.86 ALDH1A1 (0.47) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL83747 0.86 EPOR (0.54) L3MBTL1LMNAALDH1A1POLBHSD17B10
SCHEMBL12799366 0.86 ALDH1A1 (0.47) L3MBTL1LMNAALDH1A1POLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072437-A1 HETEROARYL COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS ALPHINA THERAPEUTICS, INC. (US) 2025-04-03 WO disclosed